I am a
Home I AM A Search Login

Papers of the Week


Papers: 11 Jun 2022 - 17 Jun 2022


Pharmacology/Drug Development


2022 Jun 13


Dermatology

Efficacy and Safety of Multiple Dupilumab Dose Regimens in Patients with Moderate-To-Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

Abstract

Dupilumab ameliorates the signs and symptoms of atopic dermatitis (AD) and improves the patient's quality of life. Multiple-dose regimens of dupilumab have been applied by clinicians, but the efficacy of some regimens remains unclear.